Cardinal Health (CAH) FY2013 results: revenue $101.1 billion, down 6.0% on the year
Cardinal Health Inc. (CAH) reported revenue of $101.1 billion for fiscal 2013, the year ended 30 June 2013, down 6.0% on the year before. Net income was $334 million, down 68.8%, and diluted earnings per share $0.97. The figures are the company's own, from the 10-K it filed with the SEC on 20 August 2013.
Revenue
$101.1 billion
-6.0% on the year
FY2008FY2013
Operating margin
1.0%
1.7% a year earlier
FY2008FY2013
Net income
$334 million
-68.8% on the year
FY2008FY2013
Diluted EPS
$0.97
-68.3% on the year
FY2008FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
101,093
107,552
102,644
-6.0%
Cost of revenue
96,172
103,011
98,482
-6.6%
Gross profit
4,921
4,541
4,162
+8.4%
Gross margin
4.9%
4.2%
4.1%
Selling, general and administrative
2,875
2,677
2,528
+7.4%
Operating income
996
1,792
1,514
-44.4%
Operating margin
1.0%
1.7%
1.5%
Interest expense
123
95.0
93.0
+29.5%
Pre-tax income
888
1,698
1,518
-47.7%
Income tax
553
628
552
-11.9%
Effective tax rate
62.3%
37.0%
36.4%
Net income
334
1,069
959
-68.8%
Net margin
0.3%
1.0%
0.9%
Diluted EPS
$0.97
$3.06
$2.72
-68.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
1,727
1,176
1,395
+46.9%
Capital expenditure
195
260
291
-25.0%
Free cash flow
1,532
916
1,103
+67.2%
Free cash flow margin
1.5%
0.9%
1.1%
Cash from investing
-2,375
-377
-2,028
Cash from financing
275
-454
-193
Depreciation and amortisation
397
325
313
+22.2%
Share-based compensation
93.0
85.0
80.0
+9.4%
Buybacks
450
450
270
0.0%
Dividends paid
353
300
274
+17.7%
Dividend per share
$1.02
$0.86
$0.78
+19.2%
Diluted shares, weighted
344m
349m
352m
-1.4%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
5,975
6,244
5,849
-4.3%
Debt
3,854
2,894
2,502
+33.2%
Other liabilities
15,990
15,122
14,495
+5.7%
Total liabilities and equity
25,819
24,260
22,846
+6.4%
Fixed assets
1,489
1,551
1,512
-4.0%
Goodwill
4,601
3,978
3,846
+15.7%
Intangible assets
973
414
413
+135.0%
Investments
n/a
n/a
0.0
Cash and equivalents
1,901
2,274
1,929
-16.4%
Receivables
6,304
6,355
6,156
-0.8%
Inventory
8,373
7,864
7,334
+6.5%
Other assets
2,178
1,824
1,656
+19.4%
Total assets
25,819
24,260
22,846
+6.4%
10-K for the year ended 30 June 2013, filed 20 August 2013: the filing.